- Home
- GPCR vs OPK Comparison
GPCR vs OPK Comparison
Compare GPCR & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- OPK
- Stock Information
- Founded
- GPCR 2016
- OPK 2007
- Country
- GPCR United States
- OPK United States
- Employees
- GPCR N/A
- OPK N/A
- Industry
- GPCR
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- GPCR
- OPK Health Care
- Exchange
- GPCR Nasdaq
- OPK Nasdaq
- Market Cap
- GPCR 1.2B
- OPK 1.1B
- IPO Year
- GPCR 2023
- OPK 1995
- Fundamental
- Price
- GPCR $27.28
- OPK $1.56
- Analyst Decision
- GPCR Strong Buy
- OPK Buy
- Analyst Count
- GPCR 8
- OPK 3
- Target Price
- GPCR $69.57
- OPK $2.63
- AVG Volume (30 Days)
- GPCR 1.0M
- OPK 2.7M
- Earning Date
- GPCR 11-12-2025
- OPK 11-06-2025
- Dividend Yield
- GPCR N/A
- OPK N/A
- EPS Growth
- GPCR N/A
- OPK N/A
- EPS
- GPCR N/A
- OPK N/A
- Revenue
- GPCR N/A
- OPK $664,029,000.00
- Revenue This Year
- GPCR N/A
- OPK N/A
- Revenue Next Year
- GPCR N/A
- OPK $0.84
- P/E Ratio
- GPCR N/A
- OPK N/A
- Revenue Growth
- GPCR N/A
- OPK N/A
- 52 Week Low
- GPCR $13.22
- OPK $1.11
- 52 Week High
- GPCR $43.46
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- GPCR 68.40
- OPK 65.51
- Support Level
- GPCR $25.65
- OPK $1.51
- Resistance Level
- GPCR $28.12
- OPK $1.57
- Average True Range (ATR)
- GPCR 1.60
- OPK 0.07
- MACD
- GPCR 0.28
- OPK 0.01
- Stochastic Oscillator
- GPCR 89.60
- OPK 86.36
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.